Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Dabelsteen

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|July 14, 2023
Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated ProteinsMikkel K M Aasted, Aaron C Groen, John T Keane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2014
IL-1β-dependent activation of dendritic epidermal T cells in contact hypersensitivityMorten M Nielsen, Paola Lovato, Amanda S MacLeod, et al.
EMBO Reports|April 25, 2020
O-glycan initiation directs distinct biological pathways and controls epithelial differentiationIeva Bagdonaite, Emil Mh Pallesen, Zilu Ye, et al.
Oncotarget|April 28, 2015
Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphomaBritt Lauenborg, Louise Christensen, Ulrik Ralfkiaer, et al.
Oncotarget|May 10, 2015
Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patientsIeva Bagdonaite, Hans H Wandall, Ivan V Litvinov, et al.
Science Signaling|November 22, 2022
Characterization of TGF-β signaling in a human organotypic skin model reveals that loss of TGF-βRII induces invasive tissue growthZilu Ye, Gülcan Kilic, Sally Dabelsteen, et al.
Leukemia & Lymphoma|September 6, 2012
Vascular endothelial growth factor receptor-3 expression in mycosis fungoidesIda Holst Pedersen, Andreas Willerslev-Olsen, Claudia Vetter-Kauczok, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2018
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivityCaroline B K Mathiesen, Michael C Carlsson, Stephanie Brand, et al.
Nature Communications|November 3, 2023
Glycoengineered keratinocyte library reveals essential functions of specific glycans for all stages of HSV-1 infectionIeva Bagdonaite, Irina N Marinova, Asha M Rudjord-Levann, et al.
Glycobiology|January 17, 2023
CRISPR-screen identifies ZIP9 and dysregulated Zn2+ homeostasis as a cause of cancer-associated changes in glycosylationTroels Boldt Rømer, Fawzi Khoder-Agha, Mikkel Koed Møller Aasted, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|July 14, 2023
Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated ProteinsMikkel K M Aasted, Aaron C Groen, John T Keane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2014
IL-1β-dependent activation of dendritic epidermal T cells in contact hypersensitivityMorten M Nielsen, Paola Lovato, Amanda S MacLeod, et al.
EMBO Reports|April 25, 2020
O-glycan initiation directs distinct biological pathways and controls epithelial differentiationIeva Bagdonaite, Emil Mh Pallesen, Zilu Ye, et al.
Oncotarget|April 28, 2015
Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphomaBritt Lauenborg, Louise Christensen, Ulrik Ralfkiaer, et al.
Oncotarget|May 10, 2015
Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patientsIeva Bagdonaite, Hans H Wandall, Ivan V Litvinov, et al.
Science Signaling|November 22, 2022
Characterization of TGF-β signaling in a human organotypic skin model reveals that loss of TGF-βRII induces invasive tissue growthZilu Ye, Gülcan Kilic, Sally Dabelsteen, et al.
Leukemia & Lymphoma|September 6, 2012
Vascular endothelial growth factor receptor-3 expression in mycosis fungoidesIda Holst Pedersen, Andreas Willerslev-Olsen, Claudia Vetter-Kauczok, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2018
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivityCaroline B K Mathiesen, Michael C Carlsson, Stephanie Brand, et al.
Nature Communications|November 3, 2023
Glycoengineered keratinocyte library reveals essential functions of specific glycans for all stages of HSV-1 infectionIeva Bagdonaite, Irina N Marinova, Asha M Rudjord-Levann, et al.
Glycobiology|January 17, 2023
CRISPR-screen identifies ZIP9 and dysregulated Zn2+ homeostasis as a cause of cancer-associated changes in glycosylationTroels Boldt Rømer, Fawzi Khoder-Agha, Mikkel Koed Møller Aasted, et al.
Pageof 5